Vecht CJ - Search Results

1

Phase I study of DABIS maleate given once every 3 weeks.

van der Burg ME, Planting AS, Stoter G, McDaniel C, Vecht CJ, Verweij J. van der Burg ME, et al. Among authors: vecht cj. Eur J Cancer. 1991;27(12):1635-7. doi: 10.1016/0277-5379(91)90433-e. Eur J Cancer. 1991. PMID: 1782074

2

Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in metastatic malignant melanoma.

Planting AS, van der Burg ME, Goey SH, Schellens JH, Vecht C, de Boer-Dennert M, Stoter G, Verweij J. Planting AS, et al. Eur J Cancer. 1996 Oct;32A(11):2026-8. doi: 10.1016/0959-8049(96)00187-6. Eur J Cancer. 1996. PMID: 8943692 Clinical Trial.

3

Neurotoxicity is not enhanced by increased dose intensities of cisplatin administration.

Hilkens PH, van der Burg ME, Moll JW, Planting AS, van Putten WL, Vecht CJ, van den Bent MJ. Hilkens PH, et al. Among authors: vecht cj. Eur J Cancer. 1995;31A(5):678-81. doi: 10.1016/0959-8049(94)00497-s. Eur J Cancer. 1995. PMID: 7640038 Clinical Trial.

4

Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas.

van den Bent MJ, Schellens JH, Vecht CJ, Sillevis Smit PA, Loosveld OJ, Ma J, Tijssen CC, Jansen RL, Kros JM, Verweij J. van den Bent MJ, et al. Among authors: vecht cj. Eur J Cancer. 1998 Sep;34(10):1570-4. doi: 10.1016/s0959-8049(98)00138-5. Eur J Cancer. 1998. PMID: 9893630 Clinical Trial.

5

Paclitaxel (Taxol) induces cumulative mild neurotoxicity.

van Gerven JM, Moll JW, van den Bent MJ, Bontenbal M, van der Burg ME, Verweij J, Vecht CJ. van Gerven JM, et al. Among authors: vecht cj. Eur J Cancer. 1994;30A(8):1074-7. doi: 10.1016/0959-8049(94)90459-6. Eur J Cancer. 1994. PMID: 7654432

6

Peripheral neurotoxicity induced by docetaxel.

Hilkens PH, Verweij J, Stoter G, Vecht CJ, van Putten WL, van den Bent MJ. Hilkens PH, et al. Among authors: vecht cj. Neurology. 1996 Jan;46(1):104-8. doi: 10.1212/wnl.46.1.104. Neurology. 1996. PMID: 8559354

7

Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin.

Hilkens PH, Pronk LC, Verweij J, Vecht CJ, van Putten WL, van den Bent MJ. Hilkens PH, et al. Among authors: vecht cj. Br J Cancer. 1997;75(3):417-22. doi: 10.1038/bjc.1997.68. Br J Cancer. 1997. PMID: 9020489 Free PMC article. Clinical Trial.

8

Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere).

Hilkens PH, Verweij J, Vecht CJ, Stoter G, van den Bent MJ. Hilkens PH, et al. Among authors: vecht cj. Ann Oncol. 1997 Feb;8(2):187-90. doi: 10.1023/a:1008245400251. Ann Oncol. 1997. PMID: 9093729 Free article.

9

Phase II study of weekly dose-intensified cisplatin chemotherapy with oral etoposide in recurrent glioma.

van den Bent MJ, Pronk L, Sillevis Smitt PA, Vecht CJ, Eskens FA, Verweij J. van den Bent MJ, et al. Among authors: vecht cj. J Neurooncol. 1999 Aug;44(1):59-64. doi: 10.1023/a:1006201909435. J Neurooncol. 1999. PMID: 10582670 Clinical Trial.

10

Clinical course and risk factors of neurotoxicity following cisplatin in an intensive dosing schedule.

Hilkens PH, Planting AS, van der Burg ME, Moll JW, van Putten WL, Vecht CJ, van den Bent MJ. Hilkens PH, et al. Among authors: vecht cj. Eur J Neurol. 1994 Sep;1(1):45-50. doi: 10.1111/j.1468-1331.1994.tb00049.x. Eur J Neurol. 1994. PMID: 24283428

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters